Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Alphabet's scale in cloud, search, and multimodal AI gives it a clearer path to near-term monetization than Apple's device-first approach. Valuation, cash flow and technicals create an actionable long trade: enter near $300, stop at $281, target $350 over the next 45 trading days while watching cloud customer growth and Gemini monetization as catal…
The White House has prepared detailed operational plans that would rely on British facilities - Diego Garcia and RAF Fairford - for potential strikes on Iran. The UK has not given prior approval for use of those bases for such an operation, citing worries about compliance with international law. In response to the absence of clearance, President Tr…
Gencor (GENC) sits on a $57.4 million backlog and $147.7 million in cash and securities with no debt. That mix - an orderbook large relative to trailing annual sales and a net-cash balance sheet - supports a long trade into fiscal 2026 as order conversion resumes. Entry $15.14, stop $13.50, target $20.00, long-term (180 trading days).
A cluster of high-value insider trades was disclosed on Wednesday, February 18, 2026. Director-level purchases of First American Financial Corp and KKR & Co. led the buying activity, while substantial sales at Johnson & Johnson, Howmet Aerospace and other firms accounted for the day’s largest disposals. Several transactions were executed under pre-…
KeyBanc has reiterated an Overweight rating on Autodesk Inc. (ADSK) and set a $365.00 price target, implying roughly 59% upside from the current share price. The broker's quarter-end checks came in ahead of expectations and align with the company’s positive preannouncement, while company actions including a global restructuring and an early January…
BMO Capital Markets raised its price target on Booking Holdings to $6,200 from $6,000 and kept an Outperform rating after the company reported fourth-quarter 2025 results that beat Street expectations on bookings and adjusted EBITDA. While the top-line outlook for 2026 topped consensus, margins came in below Street expectations as management earmar…
Rosenblatt Securities reiterated a Buy rating and a $50.00 price target on Applied Optoelectronics (AAOI) ahead of the company's fiscal fourth-quarter earnings, forecasting continued revenue momentum driven by growing Amazon business and initial volume 800G transceiver shipments. The firm expects roughly $133 million in Q4 revenue and projects mean…
Fiverr drew multiple analyst downgrades following an earnings report and guidance that highlighted a more challenging transition to higher-value customers. While higher-ticket transactions are strengthening, revenue and EBITDA guidance for Q1 and 2026 missed consensus and prompted concerns about execution risk, subdued marketplace trends and near-t…
Andrew Mountbatten-Windsor was detained on his 66th birthday as police investigate whether he leaked government material to Jeffrey Epstein, in connection with alleged misconduct in a public office during his tenure as a UK trade envoy. The arrest compounds decades of controversies that have eroded his public standing, including a civil settlement …
Nu Skin (NUS) trades at depressed multiples despite positive free cash flow, a modest debt load, and returns on capital consistent with a healthy business. This trade idea lays out a long trade with defined entry, stop, and target using current valuation and technical context - the idea is to own the stock while management executes on customer acqu…
Guggenheim increased its price target on NewAmsterdam Pharma to $45 from $41 and kept a Buy rating after moving up its estimate for an EU launch of obicetrapib to 2027 from 2029. The firm cited faster regulatory timing and ongoing progress in the PREVAIL outcomes trial, while broader analyst sentiment remains bullish and regulatory milestones for 2…
Bernstein SocGen Group increased its price target on Analog Devices to $375 from $270 while maintaining a Market Perform rating. The firm raised its fiscal 2027 EPS estimate and applied a higher earnings multiple, even as other brokers pushed up targets after strong quarterly results and a dividend increase. Valuation concerns and recent strong sha…
Guggenheim reduced its 12-month price target on DoorDash Inc. to $255 from $275 while keeping a Buy recommendation. The firm pointed to stronger-than-expected marketplace order trends and raised top-line forecasts but trimmed the target to reflect multiple compression across the tech sector. Management reiterated its 2026 margin guidance and outlin…
Summary: Needham increased its price target on Clean Harbors (CLH) to $308 from $290 and kept a Buy rating after the company's fourth-quarter results beat consensus on both revenue and adjusted EBITDA. The stock trades near $276.25 with an implied upside of about 11.5% to the new target. Clean Harbors reported its strongest quarterly revenue growth…
BMO Capital lowered its rating on Mister Car Wash Inc. (MCW) from Outperform to Market Perform and adjusted its price target to $7.00, aligning with Leonard Green & Partners' all-cash proposal to buy the remaining 33% stake for $764.9 million. The move follows a recent surge in the stock and coincided with the company reporting stronger-than-expect…
Needham raised its price objective on Bel Fuse Inc. (NASDAQ: BELFB) to $250 from $212 while retaining a Buy rating after fourth-quarter results beat expectations on revenue, gross margin and earnings. The company reported a 17% year-over-year sales increase in Q4, book-to-bill of 1.3, and guidance pointing to healthy first-quarter revenue growth, e…
Scotiabank increased its price target on FirstEnergy to $56 from $55 and kept a Sector Outperform rating, citing a larger capital expenditure program and upward adjustments to its estimates. FirstEnergy reported fiscal 2025 adjusted EPS of $2.55 and revenue of $15.1 billion, and reaffirmed 2026 guidance; the firm now forecasts roughly 8% earnings g…
Needham raised its price target on MKS Instruments to $300 from $260 and kept a Buy rating after the company delivered stronger-than-expected guidance for the first quarter and reported solid fourth-quarter results. The firm highlighted continued strength in the Electronics & Packaging segment and increased shipments in the Semi division. MKS also …
Guggenheim raised its price objective on Wingstop to $315 from $300 while keeping a Buy rating, reflecting higher 2026 EBITDA and EPS estimates after the company's fourth-quarter 2025 results. The new target implies about 13% upside from a quoted share price of $279.08, though InvestingPro data indicates the stock may be trading slightly above its …
Capital Economics analysts say that fresh U.S. strikes on Iran could disrupt oil supplies, lifting Brent crude and reducing the scope or timing of expected interest rate cuts by major central banks. Analysts point to recent geopolitical tensions, a spike in Brent near $70 per barrel, and Iran's role in global oil flows and control of the Strait of …
Southern Co raised its planned capital expenditures for 2026-2030 to about $81 billion and reported fourth-quarter adjusted earnings that missed analyst forecasts. The company said it has contracted 10 gigawatts of large-load customers and expects adjusted 2026 earnings slightly below consensus, while operating costs outpaced revenue growth for the…
Needham raised its price target for Allegro MicroSystems Inc. to $45 from $41 while keeping a Buy rating, after attending the company's Analyst Day in Boston. The $45 target implies roughly 17% upside from the prevailing share price. At the event, Allegro provided a 3-5 year financial blueprint that includes mid-teens revenue growth, non-GAAP gross…
Bernstein SocGen Group cut its price objective on Insulet Corporation to $330 from $380 while retaining an Outperform rating, citing mounting competition in the insulin pump market and investor unease from recent prescription data. The firm lowered its fiscal 2027 price-to-sales multiple to 6.0x and flagged persistent high earnings multiples versus…
Cantor Fitzgerald reduced its price objective for Booking Holdings to $4,495 from $5,830 while maintaining a Neutral stance. The downgrade reflects concerns about AI-related risks that may weigh on valuation multiples, even as Booking delivered stronger-than-expected fourth-quarter operating results and returned capital to shareholders.
Bernstein SocGen Group increased its price target on Amrize Ltd (NYSE:AMRZ) to $75 from $70 and kept an Outperform rating, pointing to the company's fiscal 2026 guidance as a key driver. Amrize projects 4% to 6% revenue growth and 8% to 11% EBITDA growth, with the latter expected across both Building Materials and Building Envelope segments. The fi…
